ENG/中
美国
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
和誉-B
6.840
+0.120
1.79%
手动刷新
成交量:
368.80万
成交额:
2,519.39万
市值:
46.44亿
市盈率:
144.11
高:
6.970
开:
6.650
低:
6.560
收:
6.720
数据加载中...
总览
公司
新闻
公告
和誉-B03月31日遭主力抛售321万元
市场透视
·
03-31
和誉-B03月26日获主力加仓116万元
市场透视
·
03-26
和誉-B盘中涨超4% 治疗软骨发育不全药物临床申请获CDE批准
新浪港股
·
03-26
港股异动 | 和誉-B(02256)涨超4% 治疗软骨发育不全药物临床申请获CDE批准
智通财经
·
03-26
和誉-B(02256):高选择性FGFR2/3抑制剂ABSK061用于治疗软骨发育不全的IND申请获CDE批准
智通财经
·
03-26
港股异动 | 和誉-B(02256)涨超8% 附属与艾力斯就ABSK043与枸橼酸戈来雷塞片的联合治疗达成合作协议
智通财经
·
03-24
和誉(02256.HK)附属与艾力斯就肺癌联合治疗达合作协议
阿斯达克财经
·
03-24
和誉-B:与艾力斯就ABSK043与枸橼酸戈来雷塞片联合用于治疗NSCLC达成合作协议
格隆汇
·
03-24
【和誉-B(02256.HK)附属与艾力斯就ABSK043与枸橼酸戈来雷塞片联合用于治疗NSCLC达成合作协议】和誉-B(02256.HK)发布公告,公司的附属公司上海和誉生物医药科技有限公司(和誉医药)今日宣布,已与上海艾力斯医药科技股份有限公司(艾力斯,上交所代码:688578)达成合作协议,探索将和誉医药在研的口服PD-L1 抑制剂ABSK043与艾力斯的KRAS-G12C抑制剂枸橼酸戈来雷塞片联合用于治疗 KRAS-G12C突变的非小细胞肺癌患者。
金融界
·
03-24
和誉-B(02256)附属与艾力斯就ABSK043与枸橼酸戈来雷塞片联合用于治疗NSCLC达成合作协议
智通财经
·
03-24
和誉-B03月20日主力净流入2550万元 散户资金抛售
市场透视
·
03-20
和誉-B午前涨逾5% 中金将其目标价上升至9.20港元
新浪港股
·
03-20
港股异动 | 和誉-B(02256)涨超5% 公司首年扭亏及启动2亿港元回购 创新管线今年有望迎来密集收获
智通财经
·
03-20
和誉-B(02256)3月17日斥资158.84万港元回购20万股
智通财经
·
03-17
和誉-B(02256)3月14日耗资约157.88万港元回购20万股
智通财经
·
03-14
和誉-B盘中异动 早盘急速拉升5.05%报7.900港元
市场透视
·
03-14
和誉-B获创始人徐耀昌增持4万股
新浪港股
·
03-14
和誉-B(02256.HK)主席均价7.57元增持4万股
阿斯达克财经
·
03-14
和誉-B:ABSK021的TGCTIII期结果优秀 ABSK011将启动HCCIII期临床事件
天风证券
·
03-14
和誉-B(02256)获创始人徐耀昌增持4万股
智通财经
·
03-13
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02256/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02256","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02256\",,,,,undefined,":{"symbol":"02256","market":"HK","secType":"STK","nameCN":"和誉-B","latestPrice":6.84,"timestamp":1744877289030,"preClose":6.72,"halted":0,"volume":3688000,"delay":0,"floatShares":679000000,"shares":679000000,"eps":0.04746242548929794,"marketStatus":"休市中","change":0.12,"latestTime":"04-17 16:08:09","open":6.65,"high":6.97,"low":6.56,"amount":25193938,"amplitude":0.061012,"askPrice":6.86,"askSize":101000,"bidPrice":6.83,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":0.04252799187155977,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":7,"adr":0,"listingDate":1634054400000,"exchange":"SEHK","adjPreClose":6.72,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"volumeRatio":0.6651351244946441,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02256\",,,,,undefined,":{"symbol":"02256","floatShares":679000000,"roa":"-0.64%","roe":"1.44%","lyrEps":0.047462,"volumeRatio":0.6651351244946441,"shares":679000000,"dividePrice":0,"high":6.97,"amplitude":0.061012,"preClose":6.72,"low":6.56,"week52Low":2.73,"pbRate":"2.23","psRate":"8.67","week52High":8.98,"institutionHeld":0,"latestPrice":6.84,"committee":-0.980392,"eps":0.04746242548929794,"divideRate":0,"volume":3688000,"delay":0,"ttmEps":0.04252799187155977,"open":6.65,"prevYearClose":4.6,"prevWeekClose":6.83,"prevMonthClose":8.48,"prevQuarterClose":8.48,"fiveDayClose":6.51,"twentyDayClose":8.05,"sixtyDayClose":4.51},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02256\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2523929119","title":"和誉-B03月31日遭主力抛售321万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2523929119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523929119?lang=zh_cn&edition=fundamental","pubTime":"2025-03-31 16:16","pubTimestamp":1743408991,"startTime":"0","endTime":"0","summary":"03月31日, 和誉-B股价跌0.70%,报收8.48元,成交金额9438万元,换手率1.66%,振幅9.60%,量比1.83。和誉-B今日主力资金净流出321万元,连续3日净流出,上一交易日主力净流出16万元。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为35.71%,平均跌幅为4.46%。该股近5个交易日上涨0.82%,主力资金累计净流出392万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入2683万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250331165949a448567f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250331165949a448567f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1161","02256"],"gpt_icon":0},{"id":"2522446458","title":"和誉-B03月26日获主力加仓116万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522446458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522446458?lang=zh_cn&edition=fundamental","pubTime":"2025-03-26 16:15","pubTimestamp":1742976942,"startTime":"0","endTime":"0","summary":"03月26日, 和誉-B股价涨5.10%,报收8.25元,成交金额2653万元,换手率0.48%,振幅6.24%,量比0.38。和誉-B今日主力资金净流入116万元,上一交易日主力净流入167万元。该股近5个交易日上涨1.61%,主力资金累计净流入1308万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入4199万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250326165416a4425780&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250326165416a4425780&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02256","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2522657368","title":"和誉-B盘中涨超4% 治疗软骨发育不全药物临床申请获CDE批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2522657368","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522657368?lang=zh_cn&edition=fundamental","pubTime":"2025-03-26 10:36","pubTimestamp":1742956560,"startTime":"0","endTime":"0","summary":" 和誉-B盘中涨超4%,截至发稿,股价上涨3.06%,现报8.09港元,成交额874.50万港元。 和誉医药今早宣布,其自主研发的高选择性小分子FGFR2/3抑制剂ABSK061已获中国国家药品监督管理局药品审评中心批准治疗儿童软骨发育不全的临床研究许可。据悉,ABSK061是和誉医药独立自主研发并拥有全球知识产权的一款新一代口服、高活性、高选择性小分子FGFR2/3抑制剂,也是全球范围内第一款进入临床的FGFR2/3选择性抑制剂。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-03-26/doc-ineqxyis5004425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CDE","LU2488822045.USD","BK1161","02256","BK4017"],"gpt_icon":0},{"id":"2522337868","title":"港股异动 | 和誉-B(02256)涨超4% 治疗软骨发育不全药物临床申请获CDE批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2522337868","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522337868?lang=zh_cn&edition=fundamental","pubTime":"2025-03-26 10:12","pubTimestamp":1742955126,"startTime":"0","endTime":"0","summary":"消息面上,和誉医药今早宣布,其自主研发的高选择性小分子FGFR2/3抑制剂ABSK061已获中国国家药品监督管理局药品审评中心批准治疗儿童软骨发育不全的临床研究许可。据悉,ABSK061是和誉医药独立自主研发并拥有全球知识产权的一款新一代口服、高活性、高选择性小分子FGFR2/3抑制剂,也是全球范围内第一款进入临床的FGFR2/3选择性抑制剂。和誉此前公布年度业绩。和誉同时公布,董事会已批准购回股份计划,动用不超过2亿港元于市场购回公司股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1267755.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU2488822045.USD","CDE","02256","BK4017"],"gpt_icon":0},{"id":"2522678858","title":"和誉-B(02256):高选择性FGFR2/3抑制剂ABSK061用于治疗软骨发育不全的IND申请获CDE批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2522678858","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522678858?lang=zh_cn&edition=fundamental","pubTime":"2025-03-26 08:07","pubTimestamp":1742947632,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和誉-B(02256)发布公告,公司的附属公司上海和誉生物医药科技有限公司(和誉医药)今日宣布,其自主研发的高选择性小分子FGFR2/3抑制剂ABSK061用于治疗儿童软骨发育不全的IND申请已获中国国家药品监督管理局药品审评中心批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1267690.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CDE","BK4017","LU2488822045.USD","BK1161","02256"],"gpt_icon":0},{"id":"2521731705","title":"港股异动 | 和誉-B(02256)涨超8% 附属与艾力斯就ABSK043与枸橼酸戈来雷塞片的联合治疗达成合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2521731705","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521731705?lang=zh_cn&edition=fundamental","pubTime":"2025-03-24 10:00","pubTimestamp":1742781618,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,和誉-B(02256)涨超8%,截至发稿,涨8.6%,报8.59港元,成交额2252.93万港元。消息面上,3月24日,和誉-B发布公告,公司的附属公司上海和誉生物医药科技有限公司(和誉医药)今日宣布,已与上海艾力斯医药科技股份有限公司(艾力斯,上交所代码:688578.SH)达成合作协议,探索将和誉医药在研的口服PD-L1抑制剂ABSK043与艾力斯的KRAS-G12C抑制剂枸橼酸戈来雷塞片联合用于治疗KRAS-G12C突变的非小细胞肺癌患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1266148.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688578","02256","BK0239","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2521733421","title":"和誉(02256.HK)附属与艾力斯就肺癌联合治疗达合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2521733421","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521733421?lang=zh_cn&edition=fundamental","pubTime":"2025-03-24 08:38","pubTimestamp":1742776680,"startTime":"0","endTime":"0","summary":"和誉-B(02256.HK) 公布,旗下附属公司和誉医药与艾力斯(688578.SH) 达成合作协议,探索将和誉医药在研的口服PD-L1抑制剂“ABSK043”,与艾力斯的“KRAS-G12C”抑制剂枸橼酸戈来雷塞片,联合用于治疗KRAS-G12C突变的非小细胞肺癌患者。(js/w)(港股报价延迟最少十五分钟。) (A股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20211028115122826_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20211028115122826_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1427074/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["688578","02256","BK1161","LU2488822045.USD","BK0239"],"gpt_icon":0},{"id":"2521738020","title":"和誉-B:与艾力斯就ABSK043与枸橼酸戈来雷塞片联合用于治疗NSCLC达成合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2521738020","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521738020?lang=zh_cn&edition=fundamental","pubTime":"2025-03-24 08:27","pubTimestamp":1742776022,"startTime":"0","endTime":"0","summary":"格隆汇3月24日丨和誉-B(02256.HK)发布公告,公司的附属公司上海和誉生物医药科技有限公司(“和誉医药”)今日宣布,已与艾力斯(688578.SH)达成合作协议,探索将和誉医药在研的口服PD-L1 抑制剂ABSK043与艾力斯的KRAS-G12C抑制剂枸橼酸戈来雷塞片联合用于治疗 KRAS-G12C突变的非小细胞肺癌患者。【免责声明】本文仅代表作者本人观点,与和讯网无关。和讯网站对文中陈述、观点判断保持中立,不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考,并请自行承担全部责任。邮箱:news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503240831349720c00f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503240831349720c00f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02256","688578","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2521780279","title":"【和誉-B(02256.HK)附属与艾力斯就ABSK043与枸橼酸戈来雷塞片联合用于治疗NSCLC达成合作协议】和誉-B(02256.HK)发布公告,公司的附属公司上海和誉生物医药科技有限公司(和誉医药)今日宣布,已与上海艾力斯医药科技股份有限公司(艾力斯,上交所代码:688578)达成合作协议,探索将和誉医药在研的口服PD-L1 抑制剂ABSK043与艾力斯的KRAS-G12C抑制剂枸橼酸戈来雷塞片联合用于治疗 KRAS-G12C突变的非小细胞肺癌患者。","url":"https://stock-news.laohu8.com/highlight/detail?id=2521780279","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521780279?lang=zh_cn&edition=fundamental","pubTime":"2025-03-24 08:11","pubTimestamp":1742775068,"startTime":"0","endTime":"0","summary":"和誉-B(02256.HK)发布公告,公司的附属公司上海和誉生物医药科技有限公司(和誉医药)今日宣布,已与上海艾力斯医药科技股份有限公司(艾力斯,上交所代码:688578)达成合作协议,探索将和誉医药在研的口服PD-L1 抑制剂ABSK043与艾力斯的KRAS-G12C抑制剂枸橼酸戈来雷塞片联合用于治疗 KRAS-G12C突变的非小细胞肺癌患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/24081148973245.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09939","LU1169590202.USD","161726","BK1574","159938","02256","LU2488822045.USD","BK0239","BK1515","PD","688578","LU1169589451.USD","BK1161","BK4023","399441"],"gpt_icon":0},{"id":"2521804667","title":"和誉-B(02256)附属与艾力斯就ABSK043与枸橼酸戈来雷塞片联合用于治疗NSCLC达成合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2521804667","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521804667?lang=zh_cn&edition=fundamental","pubTime":"2025-03-24 08:04","pubTimestamp":1742774699,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和誉-B(02256)发布公告,公司的附属公司上海和誉生物医药科技有限公司(和誉医药)今日宣布,已与上海艾力斯医药科技股份有限公司(艾力斯,上交所代码:688578)达成合作协议,探索将和誉医药在研的口服PD-L1 抑制剂ABSK043与艾力斯的KRAS-G12C抑制剂枸橼酸戈来雷塞片联合用于治疗 KRAS-G12C突变的非小细胞肺癌患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1266097.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02256","688578","BK1161","LU2488822045.USD","BK0239"],"gpt_icon":0},{"id":"2520438751","title":"和誉-B03月20日主力净流入2550万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2520438751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520438751?lang=zh_cn&edition=fundamental","pubTime":"2025-03-20 16:15","pubTimestamp":1742458538,"startTime":"0","endTime":"0","summary":"03月20日, 和誉-B股价涨5.59%,报收8.50元,成交金额1.37亿元,换手率2.37%,振幅10.56%,量比3.48。和誉-B今日主力资金净流入2550万元,上一交易日主力净流出51万元。该股近5个交易日上涨11.70%,主力资金累计净流入3280万元;近20日主力资金累计净流入4901万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250320165105a43b0bb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250320165105a43b0bb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02256","BK1161"],"gpt_icon":0},{"id":"2520899179","title":"和誉-B午前涨逾5% 中金将其目标价上升至9.20港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2520899179","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520899179?lang=zh_cn&edition=fundamental","pubTime":"2025-03-20 11:47","pubTimestamp":1742442420,"startTime":"0","endTime":"0","summary":" 和誉-B早盘上涨4.97%,现报8.45港元,成交额5157.87万港元。 和誉此前公布年度业绩。 近日,中金发布研报称,维持和誉-B“跑赢行业”评级,升目标价36.1%至9.2港元。由于公司创新管线进展顺利,2025年开始有望迎来密集收获,该行上调2025年净利润预测65.7%至4,473万元,并引入2026年净利润预测3.2亿元。2024年实现盈利,收入5.04亿元,同比+2,544%,符合该行预期。归母净利润2,830万元,盈利幅度超该行预期,主因运营效率高于预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-03-20/doc-ineqhmts3981347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02256"],"gpt_icon":0},{"id":"2520412342","title":"港股异动 | 和誉-B(02256)涨超5% 公司首年扭亏及启动2亿港元回购 创新管线今年有望迎来密集收获","url":"https://stock-news.laohu8.com/highlight/detail?id=2520412342","media":"智通财经","labels":["shareholding","buyback","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520412342?lang=zh_cn&edition=fundamental","pubTime":"2025-03-20 10:54","pubTimestamp":1742439264,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,和誉-B涨超5%,截至发稿,涨5.09%,报8.46港元,成交额3353.66万港元。消息面上,和誉此前公布年度业绩。和誉同时公布,董事会已批准购回股份计划,动用不超过2亿港元于市场购回公司股份。中金研报指出,由于公司创新管线进展顺利,2025年开始有望迎来密集收获。2024年内匹米替尼国际III期临床取得积极顶线结果,该行预计其2025年有希望提交新药上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1264529.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU2488822045.USD","02256"],"gpt_icon":0},{"id":"2520051723","title":"和誉-B(02256)3月17日斥资158.84万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2520051723","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520051723?lang=zh_cn&edition=fundamental","pubTime":"2025-03-17 18:02","pubTimestamp":1742205731,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和誉-B(02256)发布公告,于2025年3月17日斥资158.84万港元回购20万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1262879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","02256","BK1161"],"gpt_icon":0},{"id":"2519876501","title":"和誉-B(02256)3月14日耗资约157.88万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2519876501","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519876501?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 17:59","pubTimestamp":1741946370,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和誉-B(02256)公布,2025年3月14日耗资约157.88万港元回购20万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1262089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02256","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2519815345","title":"和誉-B盘中异动 早盘急速拉升5.05%报7.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2519815345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519815345?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 10:18","pubTimestamp":1741918719,"startTime":"0","endTime":"0","summary":"2025年03月14日早盘10时18分,和誉-B股票出现异动,股价快速上涨5.05%。资金方面,该股资金流入551.936万港元,流出420.507万港元。和誉-B股票所在的生物技术行业中,整体涨幅为1.71%。该信息摘要如下:和誉-B午前上涨6.52%,现报7.84港元,成交额2590.26万港元。中金发布研报称,由于和誉-B创新管线进展顺利,2025年开始有望迎来密集收获,该行上调2025年净利润预测65.7%至4,473万元,并引入2026年净利润预测3.2亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031410183998a6fbc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031410183998a6fbc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02256","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2519894249","title":"和誉-B获创始人徐耀昌增持4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2519894249","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519894249?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 08:38","pubTimestamp":1741912680,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 和誉-B(02256)发布公告,有关公司创始人、执行董事、首席执行官兼公司董事会主席徐耀昌博士增持公司股份的事项。董事会进一步获徐耀昌博士告知,其已于2025年3月13日于公开市场购买合计4万股公司普通股,平均价格为每股股份约港币7.57元,占公司全部已发行股份总数约0.01%。紧随购买后,徐耀昌博士于合共7998.8万股股份中拥有权益,占于本公告日期公司全部已发行股份总数约11.77%。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-03-14/doc-inepqnpx9937138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","02256","LU2488822045.USD"],"gpt_icon":0},{"id":"2519854371","title":"和誉-B(02256.HK)主席均价7.57元增持4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2519854371","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519854371?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 00:33","pubTimestamp":1741883580,"startTime":"0","endTime":"0","summary":"和誉-B(02256.HK) 公布,3月13日,创始人、首席执行官兼主席徐耀昌于公开市场购买合共4万股公司股份,每股平均价7.57元。购买后,徐博士共计持有7,998.79万股,占公司总股本11.77%。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20211028115122482_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20211028115122482_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1424525/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02256","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2519877461","title":"和誉-B:ABSK021的TGCTIII期结果优秀 ABSK011将启动HCCIII期临床事件","url":"https://stock-news.laohu8.com/highlight/detail?id=2519877461","media":"天风证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519877461?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 00:00","pubTimestamp":1741881600,"startTime":"0","endTime":"0","summary":"ABSK021 的TGCT III 期临床疗效优秀,GvHD 的20mg 剂量组未来可期ABSK021 的TGCT 适应症III 期疗效安全性双优。2024 年11 月,ABSK021治疗TGCT 的III 期MANEUVER 研究取得积极顶线结果。其GvHD 的II 期试验表现良好。目前ABSK021 正在推进全球多中心TGCT III 期临床试验及cGvHD II 期试验。ABSK011 的III 期注册临床即将启动,I 期单药数据亮眼ABSK011 的III 期注册临床已获CDE 批准。而在之前公布的,200mg BID ABSK011 单药治疗既往接受过ICI 和mTKI 治疗且FGF19过表达的HCC 患者中的ORR 为44.8%、DCR 为79.3%、mPFS 为5.5 个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314182136ab65625b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314182136ab65625b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2488822045.USD","02256"],"gpt_icon":0},{"id":"2519832605","title":"和誉-B(02256)获创始人徐耀昌增持4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2519832605","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519832605?lang=zh_cn&edition=fundamental","pubTime":"2025-03-13 21:40","pubTimestamp":1741873238,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和誉-B(02256)发布公告,有关公司创始人、执行董事、首席执行官兼公司董事会主席徐耀昌博士增持公司股份的事项。董事会进一步获徐耀昌博士告知,其已于2025年3月13日于公开市场购买合计4万股公司普通股,平均价格为每股股份约港币7.57元,占公司全部已发行股份总数约0.01%。紧随购买后,徐耀昌博士于合共7998.8万股股份中拥有权益,占于本公告日期公司全部已发行股份总数约11.77%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1261669.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02256","LU2488822045.USD","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02256\",params:#limit:5,,,undefined,":[{"date":"2025-03-03","symbol":"02256","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740965400000,"name":null,"time":"盘后","dateTimestamp":1740931200000,"actualEps":null},{"date":"2024-08-12","symbol":"02256","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723426200000,"name":null,"time":"盘后","dateTimestamp":1723392000000,"actualEps":null},{"date":"2024-03-12","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710207000000,"name":null,"time":"","dateTimestamp":1710172800000,"actualEps":null},{"date":"2023-08-15","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692063000000,"name":null,"time":"","dateTimestamp":1692028800000,"actualEps":null},{"date":"2023-03-15","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1678843800000,"name":null,"time":"","dateTimestamp":1678809600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02256\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02256\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1741363200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02256\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02256","date":"2025-04-17","current":142.082188,"percent":0.969977,"low":-234.512257,"twenty":-7.03615,"median":-3.077215,"eighty":-1.30617,"high":176.290417,"avg":-20.181758,"sd":65.169299,"marketCap":4276808796},"quantilePoints":[{"date":"2021-10-15","current":-9.313928,"twenty":-4.877635,"median":-1.919564,"eighty":-1.91666,"marketCap":8710582740},{"date":"2021-10-22","current":-8.650919,"twenty":-8.878249,"median":-8.660561,"eighty":-1.919672,"marketCap":8148609660},{"date":"2021-10-29","current":-8.806935,"twenty":-8.825514,"median":-8.653413,"eighty":-5.845693,"marketCap":8275053603},{"date":"2021-11-05","current":-9.301473,"twenty":-9.072506,"median":-8.661255,"eighty":-8.486758,"marketCap":8754126241},{"date":"2021-11-12","current":-8.237331,"twenty":-8.927135,"median":-8.653413,"eighty":-8.255925,"marketCap":7784568118},{"date":"2021-11-19","current":-7.891647,"twenty":-8.895236,"median":-8.502762,"eighty":-8.001626,"marketCap":7447330510},{"date":"2021-11-26","current":-7.829582,"twenty":-8.864707,"median":-8.396384,"eighty":-7.827763,"marketCap":7391124242},{"date":"2021-12-03","current":-7.421405,"twenty":-8.825514,"median":-8.237331,"eighty":-7.536645,"marketCap":7018757716},{"date":"2021-12-10","current":-6.897038,"twenty":-8.719527,"median":-8.053855,"eighty":-7.419956,"marketCap":6533978655},{"date":"2021-12-17","current":-6.835017,"twenty":-8.660839,"median":-7.891647,"eighty":-7.035882,"marketCap":6470746603},{"date":"2021-12-24","current":-6.74694,"twenty":-8.657769,"median":-7.827308,"eighty":-6.929689,"marketCap":6393462985},{"date":"2021-12-31","current":-6.732295,"twenty":-8.653912,"median":-7.658199,"eighty":-6.817054,"marketCap":6393462985},{"date":"2022-01-07","current":-6.564869,"twenty":-6.733406,"median":-6.682233,"eighty":-6.545813,"marketCap":6210792614},{"date":"2022-01-14","current":-5.928147,"twenty":-6.714875,"median":-6.541049,"eighty":-6.306527,"marketCap":5620626800},{"date":"2022-01-21","current":-5.914607,"twenty":-6.690644,"median":-6.454435,"eighty":-5.918405,"marketCap":5620626800},{"date":"2022-01-28","current":-5.774086,"twenty":-6.634775,"median":-6.223148,"eighty":-5.77564,"marketCap":5473085346},{"date":"2022-02-04","current":-5.576691,"twenty":-6.603137,"median":-6.042935,"eighty":-5.774086,"marketCap":5283389192},{"date":"2022-02-11","current":-4.350779,"twenty":-6.564869,"median":-5.916505,"eighty":-5.570983,"marketCap":4130278698},{"date":"2022-02-18","current":-4.318127,"twenty":-6.517229,"median":-5.781336,"eighty":-4.350779,"marketCap":4119415434},{"date":"2022-02-25","current":-3.815851,"twenty":-6.456658,"median":-5.774086,"eighty":-4.326746,"marketCap":3649226620},{"date":"2022-03-04","current":-3.520975,"twenty":-6.454435,"median":-5.57398,"eighty":-4.051501,"marketCap":3368516880},{"date":"2022-03-11","current":-3.085511,"twenty":-6.318497,"median":-5.537277,"eighty":-3.823357,"marketCap":2947452270},{"date":"2022-03-18","current":-1.525941,"twenty":-6.288573,"median":-4.578518,"eighty":-3.682078,"marketCap":3396587854},{"date":"2022-03-25","current":-1.443908,"twenty":-6.157723,"median":-4.346691,"eighty":-3.085511,"marketCap":3214126523},{"date":"2022-04-01","current":-1.328833,"twenty":-5.928147,"median":-4.322437,"eighty":-2.968177,"marketCap":2961487757},{"date":"2022-04-08","current":-1.375471,"twenty":-5.921366,"median":-4.242175,"eighty":-1.521815,"marketCap":3066753909},{"date":"2022-04-14","current":-1.437651,"twenty":-5.917771,"median":-4.006843,"eighty":-1.445834,"marketCap":3200091036},{"date":"2022-04-22","current":-1.465035,"twenty":-5.915746,"median":-3.893702,"eighty":-1.44567,"marketCap":3200091036},{"date":"2022-04-29","current":-1.247364,"twenty":-5.863479,"median":-3.81646,"eighty":-1.439188,"marketCap":2680778017},{"date":"2022-05-06","current":-1.254519,"twenty":-5.784606,"median":-3.815709,"eighty":-1.377501,"marketCap":2673760273},{"date":"2022-05-13","current":-1.307549,"twenty":-5.775886,"median":-3.520975,"eighty":-1.375471,"marketCap":2736919965},{"date":"2022-05-20","current":-1.23325,"twenty":-5.775272,"median":-3.089354,"eighty":-1.329109,"marketCap":2617618325},{"date":"2022-05-27","current":-1.250867,"twenty":-5.774086,"median":-3.004697,"eighty":-1.3182,"marketCap":2652707043},{"date":"2022-06-02","current":-1.316602,"twenty":-5.762384,"median":-2.968177,"eighty":-1.30953,"marketCap":2807097400},{"date":"2022-06-10","current":-1.15651,"twenty":-5.613245,"median":-2.229502,"eighty":-1.30593,"marketCap":2449192481},{"date":"2022-06-17","current":-1.078161,"twenty":-5.572353,"median":-1.465035,"eighty":-1.267614,"marketCap":2280766637},{"date":"2022-06-24","current":-1.093711,"twenty":-5.57104,"median":-1.447186,"eighty":-1.255725,"marketCap":2322873098},{"date":"2022-06-30","current":-1.184967,"twenty":-5.550759,"median":-1.445752,"eighty":-1.244028,"marketCap":2512352173},{"date":"2022-07-08","current":-1.296171,"twenty":-5.113983,"median":-1.443908,"eighty":-1.246415,"marketCap":2750955452},{"date":"2022-07-15","current":-1.341671,"twenty":-4.816469,"median":-1.4094,"eighty":-1.249466,"marketCap":2821132887},{"date":"2022-07-22","current":-1.367474,"twenty":-4.53297,"median":-1.376774,"eighty":-1.253058,"marketCap":2877274835},{"date":"2022-07-29","current":-1.365808,"twenty":-4.349713,"median":-1.375774,"eighty":-1.255424,"marketCap":2877274835},{"date":"2022-08-05","current":-1.372635,"twenty":-4.347615,"median":-1.371808,"eighty":-1.256374,"marketCap":2884292578},{"date":"2022-08-12","current":-1.280717,"twenty":-4.343959,"median":-1.369947,"eighty":-1.257543,"marketCap":2694813504},{"date":"2022-08-19","current":-1.206073,"twenty":-4.332903,"median":-1.367474,"eighty":-1.255424,"marketCap":2512352173},{"date":"2022-08-26","current":-1.419225,"twenty":-4.321575,"median":-1.369256,"eighty":-1.256374,"marketCap":2680778017},{"date":"2022-09-02","current":-1.491454,"twenty":-4.281721,"median":-1.37074,"eighty":-1.257543,"marketCap":2807097400},{"date":"2022-09-09","current":-1.459725,"twenty":-4.23912,"median":-1.374053,"eighty":-1.260033,"marketCap":2736919965},{"date":"2022-09-16","current":-1.23156,"twenty":-4.15674,"median":-1.374053,"eighty":-1.25723,"marketCap":2287784381},{"date":"2022-09-23","current":-1.271072,"twenty":-4.015774,"median":-1.37074,"eighty":-1.252549,"marketCap":2315855355},{"date":"2022-09-30","current":-1.195605,"twenty":-3.959398,"median":-1.369256,"eighty":-1.248765,"marketCap":2182518228},{"date":"2022-10-07","current":-1.191829,"twenty":-3.930612,"median":-1.367396,"eighty":-1.240217,"marketCap":2175500485},{"date":"2022-10-14","current":-1.32118,"twenty":-3.830419,"median":-1.367209,"eighty":-1.23903,"marketCap":2386032790},{"date":"2022-10-21","current":-1.142485,"twenty":-3.821978,"median":-1.363715,"eighty":-1.234955,"marketCap":2049181102},{"date":"2022-10-28","current":-1.026865,"twenty":-3.816338,"median":-1.357179,"eighty":-1.231371,"marketCap":1838648797},{"date":"2022-11-04","current":-1.114008,"twenty":-3.815823,"median":-1.342128,"eighty":-1.206878,"marketCap":2014092384},{"date":"2022-11-11","current":-1.342699,"twenty":-3.788983,"median":-1.336938,"eighty":-1.206878,"marketCap":2449192481},{"date":"2022-11-18","current":-1.351175,"twenty":-3.649857,"median":-1.338707,"eighty":-1.21324,"marketCap":2456210225},{"date":"2022-11-25","current":-1.358089,"twenty":-3.463579,"median":-1.335946,"eighty":-1.226609,"marketCap":2449192481},{"date":"2022-12-02","current":-1.419205,"twenty":-3.205834,"median":-1.341074,"eighty":-1.230134,"marketCap":2603582838},{"date":"2022-12-09","current":-1.425095,"twenty":-3.091661,"median":-1.342584,"eighty":-1.231371,"marketCap":2638671556},{"date":"2022-12-16","current":-1.344849,"twenty":-3.079858,"median":-1.344625,"eighty":-1.231842,"marketCap":2484281199},{"date":"2022-12-23","current":-1.177326,"twenty":-3.046735,"median":-1.342584,"eighty":-1.226609,"marketCap":2175500485},{"date":"2022-12-30","current":-1.204469,"twenty":-3.015207,"median":-1.341074,"eighty":-1.207841,"marketCap":2252695663},{"date":"2023-01-06","current":-1.106797,"twenty":-2.987775,"median":-1.336442,"eighty":-1.204712,"marketCap":2091287563},{"date":"2023-01-13","current":-1.089671,"twenty":-2.971503,"median":-1.334558,"eighty":-1.199182,"marketCap":2098305306},{"date":"2023-01-20","current":-1.124834,"twenty":-2.954945,"median":-1.333335,"eighty":-1.195449,"marketCap":2147429511},{"date":"2023-01-27","current":-1.087852,"twenty":-2.946123,"median":-1.332603,"eighty":-1.194704,"marketCap":2077252076},{"date":"2023-02-03","current":-1.188278,"twenty":-2.933064,"median":-1.331842,"eighty":-1.192669,"marketCap":2280766637},{"date":"2023-02-10","current":-1.287421,"twenty":-1.525941,"median":-1.328971,"eighty":-1.193989,"marketCap":2456210225},{"date":"2023-02-17","current":-1.281147,"twenty":-1.50531,"median":-1.328646,"eighty":-1.194704,"marketCap":2421121507},{"date":"2023-02-24","current":-1.172942,"twenty":-1.494313,"median":-1.326882,"eighty":-1.194704,"marketCap":2189535972},{"date":"2023-03-03","current":-1.157957,"twenty":-1.493734,"median":-1.321415,"eighty":-1.191829,"marketCap":2175500485},{"date":"2023-03-10","current":-1.211725,"twenty":-1.190652,"median":-1.159041,"eighty":-1.126108,"marketCap":2259713407},{"date":"2023-03-17","current":-3.757269,"twenty":-5.774798,"median":-1.344849,"eighty":-1.195881,"marketCap":2119358537},{"date":"2023-03-24","current":-3.296419,"twenty":-5.768235,"median":-1.346683,"eighty":-1.196353,"marketCap":1880755258},{"date":"2023-03-31","current":-3.65645,"twenty":-5.686352,"median":-1.351175,"eighty":-1.196881,"marketCap":2070234332},{"date":"2023-04-06","current":-3.79524,"twenty":-5.576691,"median":-1.354699,"eighty":-1.197545,"marketCap":2147429511},{"date":"2023-04-14","current":-3.717153,"twenty":-5.572353,"median":-1.357634,"eighty":-1.198435,"marketCap":2105323050},{"date":"2023-04-21","current":-3.570303,"twenty":-5.57104,"median":-1.361622,"eighty":-1.199356,"marketCap":2021110128},{"date":"2023-04-28","current":-3.399211,"twenty":-5.544018,"median":-1.366786,"eighty":-1.200488,"marketCap":1909928659},{"date":"2023-05-05","current":-1.47972,"twenty":-5.113983,"median":-1.367306,"eighty":-1.200742,"marketCap":1806339308},{"date":"2023-05-12","current":-1.457938,"twenty":-4.816469,"median":-1.368747,"eighty":-1.202979,"marketCap":1767493302},{"date":"2023-05-19","current":-1.467897,"twenty":-4.53297,"median":-1.370434,"eighty":-1.204467,"marketCap":1754544633},{"date":"2023-05-25","current":-1.457646,"twenty":-4.350068,"median":-1.372221,"eighty":-1.204631,"marketCap":1735121629},{"date":"2023-06-02","current":-1.462605,"twenty":-4.348078,"median":-1.376078,"eighty":-1.205206,"marketCap":1735121629},{"date":"2023-06-09","current":-1.502976,"twenty":-4.34487,"median":-1.378591,"eighty":-1.205852,"marketCap":1780441971},{"date":"2023-06-16","current":-1.510209,"twenty":-4.335981,"median":-1.40341,"eighty":-1.206957,"marketCap":1780441971},{"date":"2023-06-23","current":-1.48536,"twenty":-4.325022,"median":-1.411271,"eighty":-1.208646,"marketCap":1741595964},{"date":"2023-06-30","current":-1.493347,"twenty":-4.305992,"median":-1.416252,"eighty":-1.210425,"marketCap":1735121629},{"date":"2023-07-07","current":-1.4851,"twenty":-4.251341,"median":-1.419225,"eighty":-1.212479,"marketCap":1722172961},{"date":"2023-07-14","current":-1.443472,"twenty":-4.191819,"median":-1.424435,"eighty":-1.217475,"marketCap":1697389123},{"date":"2023-07-21","current":-1.455748,"twenty":-4.033638,"median":-1.428761,"eighty":-1.225478,"marketCap":1703867707},{"date":"2023-07-28","current":-1.57367,"twenty":-3.960791,"median":-1.43135,"eighty":-1.226609,"marketCap":1839917980},{"date":"2023-08-04","current":-1.510208,"twenty":-3.950465,"median":-1.43932,"eighty":-1.230134,"marketCap":1768653552},{"date":"2023-08-11","current":-1.490967,"twenty":-3.911595,"median":-1.44369,"eighty":-1.231371,"marketCap":1736260629},{"date":"2023-08-18","current":-3.132942,"twenty":-3.830419,"median":-1.444644,"eighty":-1.231842,"marketCap":1626124694},{"date":"2023-08-25","current":-2.969212,"twenty":-3.821978,"median":-1.445275,"eighty":-1.233024,"marketCap":1541903096},{"date":"2023-09-01","current":-2.956935,"twenty":-3.816338,"median":-1.446182,"eighty":-1.233589,"marketCap":1541903096},{"date":"2023-09-08","current":-3.004733,"twenty":-3.815823,"median":-1.448334,"eighty":-1.234955,"marketCap":1548381681},{"date":"2023-09-15","current":-3.01904,"twenty":-3.811615,"median":-1.451164,"eighty":-1.235394,"marketCap":1567817434},{"date":"2023-09-22","current":-2.85831,"twenty":-3.787646,"median":-1.455328,"eighty":-1.237379,"marketCap":1477858669},{"date":"2023-09-29","current":-3.059687,"twenty":-3.751278,"median":-1.457646,"eighty":-1.23903,"marketCap":1584691826},{"date":"2023-10-06","current":-3.026759,"twenty":-3.727312,"median":-1.458125,"eighty":-1.23906,"marketCap":1566886300},{"date":"2023-10-13","current":-3.077215,"twenty":-3.723642,"median":-1.459629,"eighty":-1.244992,"marketCap":1590627001},{"date":"2023-10-20","current":-3.058964,"twenty":-3.720543,"median":-1.462605,"eighty":-1.24512,"marketCap":1578756651},{"date":"2023-10-27","current":-2.991248,"twenty":-3.717831,"median":-1.465035,"eighty":-1.246735,"marketCap":1543145598},{"date":"2023-11-03","current":-3.545569,"twenty":-3.717153,"median":-1.467897,"eighty":-1.247319,"marketCap":1833969192},{"date":"2023-11-10","current":-4.143101,"twenty":-3.733303,"median":-1.474061,"eighty":-1.248161,"marketCap":2142598312},{"date":"2023-11-17","current":-4.037822,"twenty":-3.815973,"median":-1.480171,"eighty":-1.24945,"marketCap":2106987259},{"date":"2023-11-24","current":-4.106384,"twenty":-3.936201,"median":-1.481481,"eighty":-1.250638,"marketCap":2160403838},{"date":"2023-12-01","current":-4.785978,"twenty":-3.975325,"median":-1.482715,"eighty":-1.251161,"marketCap":2528384711},{"date":"2023-12-08","current":-3.891697,"twenty":-4.03647,"median":-1.4851,"eighty":-1.251909,"marketCap":2047635506},{"date":"2023-12-15","current":-4.22825,"twenty":-4.04732,"median":-1.485381,"eighty":-1.254031,"marketCap":2237561118},{"date":"2023-12-22","current":-3.928054,"twenty":-4.053689,"median":-1.486481,"eighty":-1.255725,"marketCap":2077311383},{"date":"2023-12-29","current":-4.074674,"twenty":-4.058065,"median":-1.490204,"eighty":-1.256258,"marketCap":2166339013},{"date":"2024-01-05","current":-3.788817,"twenty":-4.056443,"median":-1.492272,"eighty":-1.256918,"marketCap":2000154103},{"date":"2024-01-12","current":-3.483407,"twenty":-4.05084,"median":-1.493347,"eighty":-1.258339,"marketCap":1839904367},{"date":"2024-01-19","current":-2.914334,"twenty":-4.047812,"median":-1.494832,"eighty":-1.259474,"marketCap":1537210423},{"date":"2024-01-26","current":-2.880535,"twenty":-4.044627,"median":-1.497595,"eighty":-1.261418,"marketCap":1513469721},{"date":"2024-02-02","current":-2.567515,"twenty":-4.037992,"median":-1.4988,"eighty":-1.262107,"marketCap":1347284811},{"date":"2024-02-09","current":-2.509912,"twenty":-4.037484,"median":-1.499599,"eighty":-1.26303,"marketCap":1323544109},{"date":"2024-02-16","current":-2.700667,"twenty":-4.03647,"median":-1.502976,"eighty":-1.264369,"marketCap":1424442091},{"date":"2024-02-23","current":-2.873353,"twenty":-4.026782,"median":-1.50531,"eighty":-1.265853,"marketCap":1507534546},{"date":"2024-03-01","current":-3.007226,"twenty":-4.016267,"median":-1.510715,"eighty":-1.267104,"marketCap":1578756651},{"date":"2024-03-08","current":-2.994589,"twenty":-4.004209,"median":-1.514033,"eighty":-1.267614,"marketCap":1572821475},{"date":"2024-03-15","current":-3.717992,"twenty":-3.994485,"median":-1.516618,"eighty":-1.270393,"marketCap":1744815141},{"date":"2024-03-22","current":-3.564943,"twenty":-3.976958,"median":-1.519285,"eighty":-1.272911,"marketCap":1671460637},{"date":"2024-03-28","current":-3.64693,"twenty":-3.970449,"median":-1.523269,"eighty":-1.274866,"marketCap":1704431629},{"date":"2024-04-05","current":-3.527526,"twenty":-3.967421,"median":-1.525007,"eighty":-1.27673,"marketCap":1647541141},{"date":"2024-04-12","current":-3.689898,"twenty":-3.961738,"median":-1.534783,"eighty":-1.2803,"marketCap":1724356386},{"date":"2024-04-19","current":-3.642953,"twenty":-3.959005,"median":-1.540073,"eighty":-1.280803,"marketCap":1700964660},{"date":"2024-04-26","current":-4.107449,"twenty":-3.959005,"median":-1.565243,"eighty":-1.281169,"marketCap":1915482404},{"date":"2024-05-03","current":-4.976884,"twenty":-3.973027,"median":-1.58912,"eighty":-1.281256,"marketCap":2319333229},{"date":"2024-05-10","current":-4.784327,"twenty":-4.024444,"median":-1.91607,"eighty":-1.283533,"marketCap":2234890831},{"date":"2024-05-17","current":-5.194111,"twenty":-4.039682,"median":-2.183001,"eighty":-1.285137,"marketCap":2422751220},{"date":"2024-05-24","current":-4.64921,"twenty":-4.058631,"median":-2.509912,"eighty":-1.28634,"marketCap":2163633442},{"date":"2024-05-31","current":-4.402153,"twenty":-4.106597,"median":-2.550052,"eighty":-1.287245,"marketCap":2050744147},{"date":"2024-06-07","current":-4.13551,"twenty":-4.133471,"median":-2.567515,"eighty":-1.289289,"marketCap":1924139578},{"date":"2024-06-14","current":-4.2508,"twenty":-4.138546,"median":-2.642702,"eighty":-1.289956,"marketCap":1975968254},{"date":"2024-06-21","current":-4.357482,"twenty":-4.155859,"median":-2.683175,"eighty":-1.29202,"marketCap":2021318345},{"date":"2024-06-28","current":-4.540926,"twenty":-4.178794,"median":-2.709261,"eighty":-1.293725,"marketCap":2105539943},{"date":"2024-07-05","current":-4.513963,"twenty":-4.22771,"median":-2.729604,"eighty":-1.294301,"marketCap":2092582774},{"date":"2024-07-12","current":-4.397187,"twenty":-4.243592,"median":-2.759528,"eighty":-1.295064,"marketCap":2041442184},{"date":"2024-07-19","current":-4.220132,"twenty":-4.246463,"median":-2.788193,"eighty":-1.295793,"marketCap":1959278876},{"date":"2024-07-26","current":-4.068882,"twenty":-4.243592,"median":-2.838066,"eighty":-1.296674,"marketCap":1896076332},{"date":"2024-08-02","current":-3.881262,"twenty":-4.234933,"median":-2.853417,"eighty":-1.299007,"marketCap":1807592769},{"date":"2024-08-09","current":-4.030819,"twenty":-4.22771,"median":-2.876944,"eighty":-1.303142,"marketCap":1889756077},{"date":"2024-08-16","current":-110.215085,"twenty":-4.243592,"median":-2.92186,"eighty":-1.305862,"marketCap":1940318113},{"date":"2024-08-23","current":-110.378813,"twenty":-4.25597,"median":-2.932478,"eighty":-1.306376,"marketCap":1951413621},{"date":"2024-08-30","current":-111.169888,"twenty":-4.272942,"median":-2.946123,"eighty":-1.307217,"marketCap":1978593894},{"date":"2024-09-06","current":-112.071186,"twenty":-4.323518,"median":-2.954611,"eighty":-1.307853,"marketCap":1995595657},{"date":"2024-09-13","current":-101.344705,"twenty":-4.348078,"median":-2.964171,"eighty":-1.30892,"marketCap":1799870769},{"date":"2024-09-20","current":-109.898813,"twenty":-4.365964,"median":-2.968177,"eighty":-1.311188,"marketCap":1963495385},{"date":"2024-09-27","current":-119.045575,"twenty":-4.40116,"median":-2.97652,"eighty":-1.316813,"marketCap":2139706509},{"date":"2024-10-04","current":-139.784796,"twenty":-4.434604,"median":-2.983036,"eighty":-1.317658,"marketCap":2501057776},{"date":"2024-10-10","current":-121.076225,"twenty":-4.514518,"median":-2.991277,"eighty":-1.318017,"marketCap":2152293018},{"date":"2024-10-18","current":-136.483117,"twenty":-4.546226,"median":-2.994589,"eighty":-1.318181,"marketCap":2413520753},{"date":"2024-10-25","current":-148.160756,"twenty":-4.649306,"median":-3.00209,"eighty":-1.320584,"marketCap":2619858020},{"date":"2024-11-01","current":-152.301356,"twenty":-4.729636,"median":-3.007226,"eighty":-1.321368,"marketCap":2694889753},{"date":"2024-11-08","current":-175.184116,"twenty":-4.749387,"median":-3.020226,"eighty":-1.321799,"marketCap":3076301064},{"date":"2024-11-15","current":-156.067929,"twenty":-4.801593,"median":-3.026759,"eighty":-1.324719,"marketCap":2719900331},{"date":"2024-11-22","current":-150.055075,"twenty":-4.857642,"median":-3.029314,"eighty":-1.327756,"marketCap":2613605375},{"date":"2024-11-29","current":-166.303938,"twenty":-5.049525,"median":-3.046032,"eighty":-1.328549,"marketCap":2894974375},{"date":"2024-12-06","current":-174.977402,"twenty":-5.544018,"median":-3.050955,"eighty":-1.328637,"marketCap":3038785197},{"date":"2024-12-13","current":-157.839535,"twenty":-5.762384,"median":-3.054687,"eighty":-1.328715,"marketCap":2738658264},{"date":"2024-12-20","current":-157.261391,"twenty":-5.81235,"median":-3.05764,"eighty":-1.328813,"marketCap":2713647686},{"date":"2024-12-27","current":-161.735106,"twenty":-5.918405,"median":-3.058964,"eighty":-1.328943,"marketCap":2788679420},{"date":"2025-01-03","current":-161.576912,"twenty":-6.262403,"median":-3.0609,"eighty":-1.329656,"marketCap":2788679420},{"date":"2025-01-10","current":-160.009513,"twenty":-6.505115,"median":-3.073313,"eighty":-1.331919,"marketCap":2751163553},{"date":"2025-01-17","current":-163.8775,"twenty":-6.673144,"median":-3.085511,"eighty":-1.33225,"marketCap":2819942642},{"date":"2025-01-24","current":-170.801291,"twenty":-6.744567,"median":-3.092579,"eighty":-1.33245,"marketCap":2957500820},{"date":"2025-01-28","current":-173.143828,"twenty":-6.751024,"median":-3.096083,"eighty":-1.332653,"marketCap":3013774620},{"date":"2025-02-07","current":-175.935342,"twenty":-6.827912,"median":-3.103292,"eighty":-1.333431,"marketCap":3045037842},{"date":"2025-02-14","current":-180.702049,"twenty":-6.966007,"median":-3.137967,"eighty":-1.333994,"marketCap":3120069575},{"date":"2025-02-21","current":-234.099528,"twenty":-7.122579,"median":-3.157846,"eighty":-1.33438,"marketCap":4064218886},{"date":"2025-02-28","current":-217.890434,"twenty":-7.428225,"median":-3.248798,"eighty":-1.334681,"marketCap":3770344597},{"date":"2025-03-07","current":156.564078,"twenty":-7.428225,"median":-3.233993,"eighty":-1.333431,"marketCap":4752009774},{"date":"2025-03-14","current":163.096911,"twenty":-7.421807,"median":-3.143712,"eighty":-1.330749,"marketCap":4952094396},{"date":"2025-03-21","current":162.954964,"twenty":-7.419231,"median":-3.12686,"eighty":-1.328628,"marketCap":4945841752},{"date":"2025-03-28","current":176.290417,"twenty":-7.24304,"median":-3.099502,"eighty":-1.321703,"marketCap":5339758351},{"date":"2025-04-03","current":161.577767,"twenty":-7.123902,"median":-3.092579,"eighty":-1.318144,"marketCap":4895820596},{"date":"2025-04-11","current":142.214826,"twenty":-7.086528,"median":-3.085511,"eighty":-1.30892,"marketCap":4270556152},{"date":"2025-04-17","current":142.082188,"twenty":-7.03615,"median":-3.077215,"eighty":-1.30617,"marketCap":4276808796}],"updateTime":1745071925037}}}